Our vision as a company is to build a leading global biopharmaceutical company, while focusing on the development and commercialization of biosimilar medicines for the treatment of severe and chronic conditions, that improves the quality of life for patients around the world.
Our strategy is focused on five key pillars, incorporated in our culture and in our daily work.
Development of a relevant portfolio of biosimilar medicines through our fully integrated R&D organization and facilities
In house production of drug substance and drug product in state-of-the-art flexible biomanufacturing facility
Invest in highest quality and differentiation strategies to develop a value added and patient friendly product
Leverage partnerships with strong industry players to bring our high quality biosimilar medicines to patients all around the world
Attract best in class people and experienced leadership team to drive execution